Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Denosumab: the era of targeted therapies in bone metastatic diseases.
Santini D, Fratto ME, Vincenzi B, Napoli N, Galluzzo S, Tantardini M, Abbruzzese A, Caraglia M, Tonini G. Santini D, et al. Among authors: fratto me. Curr Cancer Drug Targets. 2009 Nov;9(7):834-42. doi: 10.2174/156800909789760375. Curr Cancer Drug Targets. 2009. PMID: 20025571 Review.
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study.
Santini D, Tampellini M, Vincenzi B, Ibrahim T, Ortega C, Virzi V, Silvestris N, Berardi R, Masini C, Calipari N, Ottaviani D, Catalano V, Badalamenti G, Giannicola R, Fabbri F, Venditti O, Fratto ME, Mazzara C, Latiano TP, Bertolini F, Petrelli F, Ottone A, Caroti C, Salvatore L, Falcone A, Giordani P, Addeo R, Aglietta M, Cascinu S, Barni S, Maiello E, Tonini G. Santini D, et al. Among authors: fratto me. Ann Oncol. 2012 Aug;23(8):2072-2077. doi: 10.1093/annonc/mdr572. Epub 2012 Jan 4. Ann Oncol. 2012. PMID: 22219016 Free article.
Zoledronic acid in the management of metastatic bone disease.
Santini D, Fratto ME, Vincenzi B, Galluzzo S, Tonini G. Santini D, et al. Among authors: fratto me. Expert Opin Biol Ther. 2006 Dec;6(12):1333-48. doi: 10.1517/14712598.6.12.1333. Expert Opin Biol Ther. 2006. PMID: 17223741 Review.
In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients.
Santini D, Martini F, Fratto ME, Galluzzo S, Vincenzi B, Agrati C, Turchi F, Piacentini P, Rocci L, Manavalan JS, Tonini G, Poccia F. Santini D, et al. Among authors: fratto me. Cancer Immunol Immunother. 2009 Jan;58(1):31-8. doi: 10.1007/s00262-008-0521-6. Epub 2008 May 6. Cancer Immunol Immunother. 2009. PMID: 18458903 Free PMC article. Clinical Trial.
Are bisphosphonates the suitable anticancer drugs for the elderly?
Santini D, Fratto ME, Galluzzo S, Vincenzi B, Tonini G. Santini D, et al. Among authors: fratto me. Crit Rev Oncol Hematol. 2009 Jan;69(1):83-94. doi: 10.1016/j.critrevonc.2008.07.008. Epub 2008 Aug 8. Crit Rev Oncol Hematol. 2009. PMID: 18692400 Review.
Targeted therapy in biliary tract cancer: 2009 update.
Tonini G, Virzì V, Fratto ME, Vincenzi B, Santini D. Tonini G, et al. Among authors: fratto me. Future Oncol. 2009 Dec;5(10):1675-84. doi: 10.2217/fon.09.130. Future Oncol. 2009. PMID: 20001803 Review.
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases.
Santini D, Perrone G, Roato I, Godio L, Pantano F, Grasso D, Russo A, Vincenzi B, Fratto ME, Sabbatini R, Della Pepa C, Porta C, Del Conte A, Schiavon G, Berruti A, Tomasino RM, Papotti M, Papapietro N, Onetti Muda A, Denaro V, Tonini G. Santini D, et al. Among authors: fratto me. J Cell Physiol. 2011 Mar;226(3):780-4. doi: 10.1002/jcp.22402. J Cell Physiol. 2011. PMID: 20857484
22 results